Beyond cholesterol lowering: effect of statins on markers of cardiovascular disease.
Levy
Yishai
Y
D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001161:Arteriosclerosis / Q000517:prevention & control*; D000069059:Atorvastatin; D002097:C-Reactive Protein / Q000187:drug effects*; D005340:Fibrinogen / Q000187:drug effects*; D006538:Heptanoic Acids / Q000494:pharmacology*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D011758:Pyrroles / Q000494:pharmacology*; D012307:Risk Factors
D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D005340:Fibrinogen; D002097:C-Reactive Protein; D000069059:Atorvastatin